Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV

被引:8
作者
Wilkinson, Sarah T. [1 ]
Fernandez, Diane R. [1 ]
Murphy, Shawn P. [2 ]
Braziel, Rita M. [3 ]
Campo, Elias [4 ]
Chan, Wing C. [5 ]
Delabie, Jan [6 ]
Gascoyne, Randy D. [7 ]
Staudt, Louis M. [8 ]
Jaffe, Elaine S. [9 ]
Rosenwald, Andreas [10 ]
Rimsza, Lisa M. [1 ]
机构
[1] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA
[2] Univ Rochester, Sch Med & Dent, Dept Obstet & Gynecol, Rochester, NY 14642 USA
[3] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA
[4] Univ Barcelona, Dept Pathol, Hosp Clin, Barcelona, Spain
[5] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA
[6] Radium Hosp, Dept Pathol, Oslo, Norway
[7] British Columbia Canc Agcy, Dept Pathol, Vancouver, BC V5Z 4E6, Canada
[8] NCI, Metab Branch, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA
[9] NCI, Hematopathol Sect, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA
[10] Univ Wurzburg, Inst Pathol, D-8700 Wurzburg, Germany
关键词
POOR PATIENT SURVIVAL; PROTEIN EXPRESSION; CIITA; GENE; MECHANISM; GAMMA;
D O I
10.3109/10428190903297531
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1875 / U187
页数:5
相关论文
共 15 条
[2]   Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL) [J].
Cycon, Kell A. ;
Rimsza, Lisa M. ;
Murphy, Shawn P. .
EXPERIMENTAL HEMATOLOGY, 2009, 37 (02) :184-194
[3]   A GENOMIC SEQUENCING PROTOCOL THAT YIELDS A POSITIVE DISPLAY OF 5-METHYLCYTOSINE RESIDUES IN INDIVIDUAL DNA STRANDS [J].
FROMMER, M ;
MCDONALD, LE ;
MILLAR, DS ;
COLLIS, CM ;
WATT, F ;
GRIGG, GW ;
MOLLOY, PL ;
PAUL, CL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (05) :1827-1831
[4]   Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-γ in haematopoietic tumour cells [J].
Morimoto, Y ;
Toyota, M ;
Satoh, A ;
Murai, M ;
Mita, H ;
Suzuki, H ;
Takamura, Y ;
Ikeda, H ;
Ishida, T ;
Sato, N ;
Tokino, T ;
Imai, K .
BRITISH JOURNAL OF CANCER, 2004, 90 (04) :844-852
[5]   Kinetics of a gamma interferon response: Expression and assembly of CIITA promoter IV and inhibition by methylation [J].
Morris, AC ;
Beresford, GW ;
Mooney, MR ;
Boss, JM .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (13) :4781-4791
[6]   Methylation of class II trans-activator promoter IV:: A novel mechanism of MHC class II gene control [J].
Morris, AC ;
Spangler, WE ;
Boss, JM .
JOURNAL OF IMMUNOLOGY, 2000, 164 (08) :4143-4149
[7]   Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA [J].
MuhlethalerMOttet, A ;
Otten, LA ;
Steimle, V ;
Mach, B .
EMBO JOURNAL, 1997, 16 (10) :2851-2860
[8]   Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP [J].
Rimsza, Lisa M. ;
LeBlanc, Michael L. ;
Unger, Joseph M. ;
Miller, Thomas P. ;
Grogan, Thomas M. ;
Persky, Daniel O. ;
Martel, Ralph R. ;
Sabalos, Constantine M. ;
Seligmann, Bruce ;
Braziel, Rita M. ;
Campo, Elias ;
Rosenwald, Andreas ;
Connors, Joseph M. ;
Sehn, Laurie H. ;
Johnson, Nathalie ;
Gascoyne, Randy D. .
BLOOD, 2008, 112 (08) :3425-3433
[9]   CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression [J].
Rimsza, Lisa M. ;
Chan, Wing C. ;
Gascoyne, Randy D. ;
Campo, Elias ;
Jaffe, Elaine S. ;
Staudt, Louis M. ;
Delabie, Jan ;
Rosenwald, Andreas ;
Murphy, Shawn P. .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (04) :596-598
[10]   Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions [J].
Rimsza, LM ;
Roberts, RA ;
Campo, E ;
Grogan, TM ;
Bea, S ;
Salaverria, I ;
Zettl, A ;
Rosenwald, A ;
Ott, G ;
Muller-Hermelink, HK ;
Delabie, J ;
Fisher, RI ;
Unger, JM ;
LeBlanc, M ;
Staudt, LM ;
Jaffe, ES ;
Gascoyne, RD ;
Chan, WC ;
Weisenburger, DD ;
Greiner, T ;
Braziel, RM ;
Miller, TP .
BLOOD, 2006, 107 (03) :1101-1107